IOPAMIDOL-250 Drug Patent Profile
✉ Email this page to a colleague
When do Iopamidol-250 patents expire, and when can generic versions of Iopamidol-250 launch?
Iopamidol-250 is a drug marketed by Cook Imaging, Fresenius Kabi Usa, and Hospira. and is included in five NDAs.
The generic ingredient in IOPAMIDOL-250 is iopamidol. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the iopamidol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Iopamidol-250
A generic version of IOPAMIDOL-250 was approved as iopamidol by HAINAN POLY on February 27th, 2023.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for IOPAMIDOL-250?
- What are the global sales for IOPAMIDOL-250?
- What is Average Wholesale Price for IOPAMIDOL-250?
Summary for IOPAMIDOL-250
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Clinical Trials: | 26 |
| Patent Applications: | 4,562 |
| DailyMed Link: | IOPAMIDOL-250 at DailyMed |
Recent Clinical Trials for IOPAMIDOL-250
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Masonic Cancer Center, University of Minnesota | PHASE2 |
| National Cancer Institute (NCI) | PHASE2 |
| Chongqing Emergency Medical Center | N/A |
US Patents and Regulatory Information for IOPAMIDOL-250
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cook Imaging | IOPAMIDOL-250 | iopamidol | INJECTABLE;INJECTION | 074881-002 | Jul 28, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | IOPAMIDOL-250 | iopamidol | INJECTABLE;INJECTION | 075005-001 | Feb 24, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fresenius Kabi Usa | IOPAMIDOL-250 | iopamidol | INJECTABLE;INJECTION | 074679-001 | Apr 2, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | IOPAMIDOL-250 | iopamidol | INJECTABLE;INJECTION | 074898-002 | Dec 30, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | IOPAMIDOL-250 IN PLASTIC CONTAINER | iopamidol | INJECTABLE;INJECTION | 074636-002 | Dec 30, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
